Company intelligence / Profile preview

ICB Pharma

Jaworzno, Poland

Ownership: Private
Employees: ~61
Development stage: Other

Overview

ICB Pharma is a Polish research-oriented chemical and medical device company with over 25 years of experience that develops and commercializes nano- and micro‑encapsulation based products in health care, pest control and crop protection, including CE‑marked medical devices for lice treatment, allergy prevention, antifungal nail care and tick protection, as well as pesticide‑free agrochemical and pest control solutions sold in about 90 countries.[3][4][5][6]

Therapeutic areas: ImmunologyCardiovascularDermatologyInfectious DiseasesRheumatology
Modalities: DeviceNon-pharmacological therapySmall molecule
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on ICB Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ICB Pharma.

Explore the full profile